Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan

International Journal of Clinical Practice

Volumn 62, Issue 12, 2008, Pages 1889-1899

  Newman, L C ^a,b   Cady, R K ^c   Landy, S ^d   O'Carroll, P ^e   Kwong, W J ^f   Burch, S P ^g   Nelsen, A C ^g   McDonald, S A ^g  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Primary Care Network   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^e University of Georgia ^*  (United States)

^f UNIVERSITY OF GEORGIA   (United States)

^g GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SUMATRIPTAN; TRIPTAN DERIVATIVE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PAIN; PATIENT SATISFACTION; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SEROTONIN AGONISTS; SUMATRIPTAN; TABLETS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 55949109069     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01935.x     Document Type: Article

References (39)

1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004 24 (Suppl. 1 1 160.
2. Stewart W, Lipton R, Celentano D, Reed M. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992 267 : 64 9.
3. Stang P, Osterhaus J. Impact of migraine in the United States: data from the National Health Interview Survey. Headache 1993 33 : 29 35.
4. Lipton R, Stewart W, Von Korff M. Burden of migraine: societal costs and therapeutic opportunities. Neurology 1997 48 (Suppl. 3 S4 9.
5. Stang PE, Crown WH, Bizier R et al. The family impact and costs of migraine. Am J Manag Care 2004 10 : 313 20.
6. Sheftell F, Bigal M, Tepper S, Rapoport A. Sumatriptan: a decade of use and experience in the treatment of migraine. Expert Rev Neurother 2004 4 : 199 209.
7. Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. N Engl J Med 1991 325 : 316 21.
8. Mathew NT, Dexter J, Couch J et al. Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group. Arch Neurol 1992 49 : 1271 6.
9. Cady RK, Wendt JK, Kirchner JR et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991 265 : 2831 5.
10. Ferrari M, Goadsby P, Roon K, Lipton R. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2004 22 : 633 58.
11. Tfelt-Hansen P, Block G, Dahlöf C et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000 20 : 765 87.
12. Cady R, Lipton R, Hall C et al. Treatment of mild headache in disabled migraine sufferers: results of the Spectrum study. Headache 2000 40 : 792 7.
13. Martin V, Cady R, Mauskop A et al. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (treat a migraine early) studies. Headache 2008 48 : 226 35.
14. Dowson AJ, Mathew NT, Pascual J. Review of clinical trials using early acute intervention with oral triptans for migraine management. Int J Clin Pract 2006 60 : 698 706.
15. Becker W, Christie S, Ahmad F. Pain-free efficacy of sumatriptan in the treatment of migraine at the first sign of-pain: Prospective, double-blind, placebo-controlled Canadian multicenter study of sumatriptan 50 mg and 100 mg versus placebo (Abstract). Cephalalgia. 2003 23 : 692.
16. Cady R, Sheftell F, Lipton R et al. Effects of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000 22 : 1035 48.
17. Scholpp J, Schellenberg R, Moeckesch B, Banik N. Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia 2004 24 : 925 33.
18. Winner P, Landy S, Richardson M, Ames M. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Clin Ther 2005 27 : 1785 94.
19. Winner P, Mannix L, Putnam D et al. Pain-free results with sumatriptan taken at the first sign of-migraine pain: 2 randomized, double-blind, placebo-controlled studies. Mayo Clin Proc 2003 78 : 1214 22.
20. D'Amico D, Moschiano F, Usai S, Bussone G. Treatment strategies in the acute therapy of migraine: stratified care and early intervention. Neurol Sci 2006 27 (Suppl. 2 S117 22.
21. Cady R, Sheftell F, Lipton R et al. Economic implications of early treatment of migraine with sumatriptan tablets. Clin Ther 2001 23 : 284 91.
22. Halpern MT, Lipton RB, Cady RK et al. Costs and outcomes of early versus delayed migraine treatment with sumatriptan. Headache 2002 42 : 984 99.
23. Landy S, Savani N, Shackelford S et al. Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int J Clin Pract 2004 58 : 913 9.
24. Kori S, McDonald S, Page R et al. Gastric transit and absorption of reformulated and conventional sumatriptan tablets in migraineurs both during and outside of a migraine attack: evaluation by gastric scintigraphy (abstract?). Neurology 2006 66 : A375.
25. Barbanti P, Carpay AK, Kwong JW, Ahmad F, Boswell D. Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine. Curr Med Res Opin 2004 20 : 2021 9.
26. Carpay J, Schoenen J, Ahmad F et al. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. Clin Ther 2004 26 : 214 23.
27. Shikiar R, Rentz A. Satisfaction with medication: an overview of conceptual, methodological, and regulatory issues. Value Health 2004 7 : 204 15.
28. Food and Drug Administration. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Draft Guidance. Draft Guidance. Rockville, MD : Food and Drug Administration, 2006.
29. Revicki DA, Kimel M, Beusterien K et al. Validation of the Revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment. Headache 2006 46 : 240 52.
30. Revicki D, Kimel M, Chen W-H, McCormack J. Validation of the Revised Patient Perception of Migraine Questionnaire for use in Clinical Trials: Measuring Satisfaction With Acute Migraine Treatment. Lisbon, Portugal : ISOQOL, 2006.
31. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 2003 43 : 19 26.
32. Pascual J, Munoz R, Leira R. An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients. Cephalalgia 2001 21 : 680 4.
33. Pascual J, Bussone G, Hernandez J et al. Rizatriptan-Sumatriptan Preference Study Group. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine. Eur Neurol 2001 45 : 275 83.
34. Luciani R, Osterhaus J, Gutterman D. Patient preferences for migraine therapy: subcutaneous sumatriptan compared with other medications. J Fam Pract 1995 41 : 147 52.
35. Lipton R, Hamelsky S, Dayno J. What do patients with migraine want from acute migraine treatment? Headache 2002 42 (Suppl. 1 3 9.
36. Davies G, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000 20 : 554 60.
37. Hu X, Markson L, Lipton R et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999 159 : 813 8.
38. Kwong JW. The effect of early intervention with sumatriptan tablets on migraine-associated productivity loss. J Occup Environ Med 2005 47 : 1167 73.
39. Ng-Mak DS, Cady R, Chen Y-T et al. Can migraineurs accurately identify their headaches as "migraine" at attack onset? Headache 2007 47 : 645 53.